7Suppliers
0Customers
3Debt Items
0Related Chains

Source-Backed Evidence Depth

Reviva Pharmaceuticals Holdings, Inc. (RVPH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
3Distinct source URLs
8High confidence
0.829Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Reviva Pharmaceuticals Holdings, Inc. Suppliers

TickerNameConfidenceEvidence
API-CONTRACT-MANUFACTURER API-CONTRACT-MANUFACTURER 92% We have an API contract manufacturer to produce bulk batches under GMP for our anticipated clinical studies
CONTRACT-RESEARCH-ORGANIZATIONS CONTRACT-RESEARCH-ORGANIZATIONS 92% The Company determines the amounts to accrue by obtaining reports from its vendors, including the Company's contract research organizations ("CROs"),
CROS CROS 92% The Company determines the amounts to accrue by obtaining reports from its vendors, including the Company's contract research organizations ("CROs"),
VENDOR VENDOR 90% during the nine months ended September 30, 2024 costs from two vendors each represented 37 % and 17 % of total research and development expenses, respectively
B-RILEY-SECURITIES-INC B-RILEY-SECURITIES-INC 62% al processes; ● our ability to obtain the necessary financing to continue to conduct our business operations as planned, and to conduct our ongoing and planned trials, and continue and complete the p…
OTC-MARKETS-GROUP OTC-MARKETS-GROUP 62% ability to maintain compliance with the continued listing requirements of the OTCQB Venture Market tier of the OTC Markets Group (“OTCQB Venture Market”); ● our ability to raise additional capital wh…
OTC-MARKETS-GROUP-INC OTC-MARKETS-GROUP-INC 62% ability to maintain compliance with the continued listing requirements of the OTCQB Venture Market tier of the OTC Markets Group (“OTCQB Venture Market”); ● our ability to raise additional capital wh…

Reviva Pharmaceuticals Holdings, Inc. Customers

No clients on recordNo downstream customers found in our database for Reviva Pharmaceuticals Holdings, Inc..

Reviva Pharmaceuticals Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RVPH-DEBT-12306 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
RVPH-DEBT Debt stack $144,093 90% Market cache reports total debt of $144,093.
RVPH-DEBT-12305 Warrants outstanding: 19075842 90% xbrl warrant detail from xbrl 2026-03-31.

Reviva Pharmaceuticals Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Reviva Pharmaceuticals Holdings, Inc..

Reviva Pharmaceuticals Holdings, Inc. Ownership

HolderNameConfidenceEvidence
RVPH-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 5 tracked holders.

Reviva Pharmaceuticals Holdings, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
RVPH
Unlock RVPH Supply Chain Data
Verified relationships include:
API-CONTRACT-MANUFACTURERAPI-CONTRACT-MANUFACTURERSupplier92%
CONTRACT-RESEARCH-ORGANIZATIONSCONTRACT-RESEARCH-ORGANIZATIONSSupplier92%
+7 more relationships locked
Subscribe — View plans →